Trial
NCT00621036
Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma
Phase IIWITHDRAWNEFFICACY/FUTILITYConfidence: HIGH
Sponsor
University of Texas Southwestern Medical Center
Collaborators
—
Condition
Brain and Central Nervous System Tumors
Intervention
autologous immunoglobulin idiotype-KLH conjugate vaccine
Why stopped
MyVax did not meet its primary endpoints
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-26